Oncology in Switzerland

Dr. Eric Fréneaux is a leading nuclear medicine specialist in Switzerland, widely recognized for his pioneering work in molecular imaging and nuclear cardiology. With over three decades of international experience in clinical practice, research, and teaching, Dr. Fréneaux has earned a reputation as one of the best doctors in Switzerland for nuclear medicine and molecular diagnostics. His commitment to innovation and patient-centered care makes him a top-rated physician in Geneva, trusted by patients and peers alike. 

Dr. Eric Fréneaux began his career as an intern at the Paris Hospitals, later joining INSERM, where he conducted research on mitochondrial oxidation of fatty acids. From 1995 to 1998, he served as a University Hospital Assistant at Cochin Hospital and René Descartes University in Paris, actively contributing to medical education. In 1998, he established and led the Nuclear Medicine Department at Ajaccio Hospital Center. He later took on leadership roles at the Clinique Générale Beaulieu, eventually becoming the head of the Nuclear Medicine Institute and later co-founding the Geneva Molecular Imaging Center (IMGE) in 2013. Currently, Dr. Fréneaux practices at the Center for Molecular Imaging and Nuclear Medicine at Hirslanden Clinique des Grangettes, where he continues to advance the field of nuclear imaging and cancer diagnostics.

Dr. Olivier Rager, a top nuclear medicine specialist, is renowned for his expertise in molecular imaging and oncological visualization. With a distinguished career in cancer research and advanced imaging technologies, he plays a pivotal role in the Network of Senology and Onco Gynecology of Geneva. As a leading oncological visualization doctor, his extensive contributions as a medical researcher at Memorial Sloan-Kettering Cancer Center have propelled advancements in PET/CT and SPECT/CT imaging, revolutionizing early cancer detection and treatment strategies. Recognized as one of the best molecular imaging experts in Switzerland, Dr. Rager remains at the forefront of cutting-edge clinical studies, driving innovations in Switzerland’s nuclear medicine field.